Concepedia

Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis

Pax H.B. Willemse, Jan van Lith, Nanno H. Mulder, Jan G. Aalders, J. Bouma, Elisabeth G.E. de Vries, Dirk Th. Sleijfer

European Journal of Cancer and Clinical Oncology · 1990 · 17 citations · 14 references

DOI

Concepts

References

14

Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer

Alan S. Coates, Val Gebski, James F. Bishop et al. · New England Journal of Medicine · 1987 · 538 citations

, , +15

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

Aron Goldhirsch, Richard D. Gelber, R. John Simes et al. · Journal of Clinical Oncology · 1989 · 336 citations

, , +15

Advanced Ovarian Adenocarcinoma

Robert C. Young, Bruce A. Chabner, Susan P. Hubbard et al. · New England Journal of Medicine · 1978 · 322 citations

, , +16

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

J.P. Neijt, W W ten Bokkel Huinink, M E van der Burg et al. · Journal of Clinical Oncology · 1987 · 312 citations

, , +17

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

George Omura, John A. Blessing, Clarence E. Ehrlich et al. · Cancer · 1986 · 283 citations · Full text

, , +17